Pendal Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-22,575
| Closed | -$859K | – | 490 |
|
|
2019
Q3 | $859K | Sell |
22,575
-1,799
| -7% | -$68.5K | 0.01% | 295 |
|
|
2019
Q2 | $1.06M | Buy |
24,374
+1,272
| +6% | +$55.3K | 0.01% | 271 |
|
|
2019
Q1 | $879K | Hold |
23,102
| – | – | 0.01% | 312 |
|
|
2018
Q4 | $994K | Sell |
23,102
-224
| -1% | -$9.64K | 0.02% | 268 |
|
|
2018
Q3 | $1.15M | Hold |
23,326
| – | – | 0.02% | 280 |
|
|
2018
Q2 | $748K | Buy |
23,326
+1,975
| +9% | +$63.3K | 0.01% | 335 |
|
|
2018
Q1 | $665K | Buy |
21,351
+286
| +1% | +$8.91K | 0.01% | 358 |
|
|
2017
Q4 | $962K | Buy |
21,065
+361
| +2% | +$16.5K | 0.01% | 305 |
|
|
2017
Q3 | $777K | Buy |
20,704
+8,196
| +66% | +$308K | 0.01% | 342 |
|
|
2017
Q2 | $597K | Buy |
+12,508
| New | +$597K | 0.01% | 347 |
|